Alphatec Holdings, Inc.
Could not find a ticker for this position, may be a filing error
A designer and seller of spinal implants, fixation systems, biologics, and surgical instruments for treating spine disorders, Alphatec centers its lineup on the Prone TransPsoas (PTP) lateral approach, SafeOp nerve monitoring, and an imaging-and-robotics platform built on EOS whole-body scans and Valence surgical navigation. The company began in 1990 as a contract manufacturer for other medical-device firms, renamed itself Alphatec Spine in 2005 to mark its shift to its own spine products, and later folded EOS imaging into its platform in 2021.
0.75% Convertible Senior Notes due 2026
Granted 32.0K
Sold 116.4K
Granted 32.0K
Sold 260.5K
Sold 79.8K
Granted 32.0K
Granted 102.5K · Sold 88.8K
Sold 163.5K
Granted 32.0K
Granted 32.0K · Bought 135.0K
Granted 32.0K · Sold 6.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Pelizzon David RDirector · 1 transaction | +0.3% | 10.77M | 32.0K | — | — |
| Miles PatrickCEO, Director · 1 transaction | +2.3% | 6.04M | — | — | — |
| Hunsaker Craig EEVP, PEOPLE & CULTURE · 3 transactions | -6.3% | 1.73M | — | — | 116.4K |
| Berkowitz Mortimer IIIDirector · 1 transaction | +2.6% | 1.26M | 32.0K | — | — |
| Lish ScottCHIEF OPERATING OFFICER · 1 transaction | -12.1% | 815.7K | — | — | 260.5K |
| Koning John ToddCHIEF FINANCIAL OFFICER · 2 transactions | -2.9% | 600.7K | — | — | 79.8K |
| Blackford Quentin S.Director · 1 transaction | +5.6% | 600.4K | 32.0K | — | — |
| Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC. · 6 transactions | +4.3% | 574.5K | 102.5K | — | 88.8K |
| Sponsel DavidEVP, SALES · 1 transaction | -24.5% | 504.9K | — | — | 163.5K |
| Demski David MDirector · 1 transaction | +8% | 431.6K | 32.0K | — | — |
| Valentine KeithDirector · 4 transactions | +171.7% | 264.3K | 32.0K | 135.0K | — |
| McGinnis Karen KDirector · 2 transactions | +37.8% | 94.7K | 32.0K | — | 6.0K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -580.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.